Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Prospective Randomized Double Blinded Control Trial Using Ketamine or Propofol Anesthesia for Electroconvulsive Therapy: Improving Treatment-Resistant Depression

To see complete record on, please visit this link

Id: NCT01935115

Organisation Name: University of Saskatchewan

Overal Status: Completed

Start Date: September 2013

Last Update: September 13, 2017

Lead Sponsor: University of Saskatchewan

Brief Summary: To determine the effect of ketamine, compared to propofol, when used an an anesthetic agent for electroconvulsive therapy (ECT) in the treatment of major depressive disorder (MDD). We hypothesize that ketamine, compared to propofol, will improve the the symptoms of MDD when used as the anesthetic agent to facilitate ECT. Additionally, we hypothesize the dissociative and cardiovascular effects of ketamine will be minimal.

  • Treatment Resistant Depression

Total execution time in seconds: 0.24246406555176